Can someone point me towards any companies looking at this? Big incumbent providers would have to be frontrunners but I am sure that some smaller companies have announced they are looking at this, I just cannot recall.
Given that the Gov flagged this as important, and potentially allocated money (im not sure) this could be a good sector to look closer at. Overnight Moderna gained FDA approval for an RSV (cause of croup and resp illness) virus in USA and looking at potentially combining this into a vaccine with season COVID booster shots to increase uptake!
Any help?